The ongoing evolution of the Rotavirus Prophylaxis Market reveals significant growth trajectories that are shaping its landscape. Valued at approximately USD 2.00 billion in 2024, the market is expected to escalate to USD 3.39 billion by 2035, reflecting a commendable growth rate. This anticipated increase is primarily fueled by an enhanced focus on vaccination programs, especially in regions...